Verrica Pharmaceuticals Overview
- Founded
- 2013

- Status
- Public
- Employees
- 17

- Stock Symbol
- VRCA

- Share Price
- $11.76
- (As of Wednesday Closing)
Verrica Pharmaceuticals General Information
Description
Verrica Pharmaceuticals Inc is a dermatology therapeutics company engaged in the development and commercialization of novel treatments that provide meaningful benefit for people living with skin diseases. Its lead product candidate, VP-102, is developed for the treatment of molluscum contagiosum, or molluscum, a highly contagious and primarily pediatric viral skin disease, and common warts.
Contact Information
- Durham, NC
- United States
Verrica Pharmaceuticals Stock Performance
(As of Wednesday Closing)
Stock Price | Previous Close | 52 wk Range | Market Cap | Shares | Average Volume | EPS |
---|---|---|---|---|---|---|
$11.76 | $11.12 | $6.02 - $17.60 | $304M | 25.9M | 69.2K | -$1.50 |
Verrica Pharmaceuticals Financials Summary
In Thousands, USD |
TTM 30-Sep-2020 | FY 2019 31-Dec-2019 | FY 2018 31-Dec-2018 | FY 2017 31-Dec-2017 |
---|---|---|---|---|
EV | 155,026 | 338,707 | 112,450 | |
Revenue | 0 | 0 | 0 | 0 |
EBITDA | (35,889) | (29,827) | (21,859) | (4,457) |
Net Income | (37,354) | (28,207) | (20,648) | (4,459) |
Total Assets | 79,936 | 68,424 | 91,906 | 9,083 |
Total Debt | 36,976 | 188 | 0 | 0 |
Verrica Pharmaceuticals Valuation & Funding
Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
---|
This information is available in the PitchBook Platform. To explore Verrica Pharmaceuticals‘s full profile, request access.
Request a free trialVerrica Pharmaceuticals Cap Table
Stock | # of Shares Authorized |
Par Value | Dividend Rate (%) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price |
% Owned |
---|
This information is available in the PitchBook Platform. To explore Verrica Pharmaceuticals‘s full profile, request access.
Request a free trialVerrica Pharmaceuticals Comparisons
Industry
0000000
00000000
PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.
Request a free trialVerrica Pharmaceuticals Competitors (8)
Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
---|---|---|---|---|---|---|
Aclaris Therapeutics | Formerly VC-backed | Wayne, PA | 00 | 00000 | 00000000000 | 00000 |
000000000 | Formerly PE-Backed | Houston, TX | 00 | 000.00 | 000000000 | 000.00 |
00000000 000000000 | Private Debt Financed | San Diego, CA | 00 | 000000000 - | ||
0000 0000000000000 | Formerly PE-Backed | West Chester, PA | 000000&0 | |||
000000 | Formerly PE-Backed | Newport Beach, CA | 000 | 00000 | 00000000 | 00000 |
Verrica Pharmaceuticals Executive Team (6)
Name | Title | Board Seat | Contact Info |
---|---|---|---|
Ted White | Chief Executive Officer & Board Member | ||
Matthew Davidson Ph.D | Founder, Chief Scientific Officer & Board Member | ||
Patrick Burnett Ph.D | Chief Medical Officer |
Verrica Pharmaceuticals Board Members (8)
Name | Representing | Role | Since |
---|---|---|---|
Lawrence Eichenfield MD | Self | Board Member | 000 0000 |
Matthew Davidson Ph.D | Verrica Pharmaceuticals | Founder, Chief Scientific Officer & Board Member | 000 0000 |
Paul Manning | PBM Capital Group | Chairman & Board Member | 000 0000 |
Sean Stalfort | Verrica Pharmaceuticals | Board Member | 000 0000 |
Ted White | Verrica Pharmaceuticals | Chief Executive Officer & Board Member | 000 0000 |
Verrica Pharmaceuticals Signals
Growth Rate

Growth

Size Multiple


Key Data Points
Twitter Followers
5.5k

Similarweb Unique Visitors
15.0K

Majestic Referring Domains
314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.
Request a free trialVerrica Pharmaceuticals Investors
Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
---|
This information is available in the PitchBook Platform. To explore Verrica Pharmaceuticals‘s full profile, request access.
Request a free trial